This inventor holds 20 USPTO granted patents and 5 published patent applications and 14 EPO patents, primarily in PDE4 Inhibitors. Top assignees: Bayer Aktiengesellschaft, Takeda Gmbh, Nycomed Gmbh. Active years: 1993-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Konstanz, DE (1993 - 1994)
- Burscheid, DE (1993 - 1995)
- Constance, DE (1994 - 2016)
Company Filing History:
9 out of 12,268 
6 out of 47 
3 out of 63 
Years Active: 1993-2016
Areas of Expertise:
Title: The Innovative Journey of Armin Hatzelmann
Introduction: Armin Hatzelmann, based in Constance, Germany, is a prominent inventor known for his contributions to the pharmaceutical industry. With a total of 20 patents to his name, Hatzelmann's work focuses on innovative compounds that address significant medical challenges.
Latest Patents: Among his latest innovations are two noteworthy patents involving Pyrazolone derivatives as inhibitors of type 4 phosphodiesterase (PDE-4). These compounds are recognized for their effectiveness in treating conditions such as psoriasis and atopic dermatitis. The detailed composition of one such invention is represented by the compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione, illustrating Hatzelmann's skill in developing novel therapeutic agents.
Career Highlights: Hatzelmann has made substantial contributions while working with renowned pharmaceutical companies like Bayer Aktiengesellschaft and Takeda GmbH. His career is marked by a series of innovations that have advanced the field of medicinal chemistry, most notably in the design and application of effective pharmaceutical compounds.
Collaborations: Throughout his career, Armin has collaborated with notable colleagues, including Siegfried Raddatz and Klaus-Helmut Mohrs. These partnerships have fostered a collaborative environment that has been instrumental in the successful development of his innovative inventions.
Conclusion: Armin Hatzelmann's work exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to research and development, coupled with significant collaborations and a strong portfolio of patents, continues to make a lasting impact on medical treatments and therapies. His journey is a testament to the importance of creativity and collaboration in the pursuit of scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile